FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2033236638> ?p ?o ?g. }

• W2033236638 endingPage "61" @default.
• W2033236638 startingPage "56" @default.
• W2033236638 abstract "Imatinib Mesylate, a Tyrosine Kinase inhibitor, is presently the drug of choice for Chronic myeloid leukemia (CML). During therapy, a few patients develop myelosuppression and present with cytopenias. To study the bone marrow morphology in imatinib treated CML patients presenting with persistent cytopenias. The cases were retrieved from the Hematopathology record files, Department of Pathology; the study period being January 2008-June 2009. Cases of CML on Imatinib presenting with grade 2 or more anemia, neutropenia and/or thrombocytopenias with bone marrow studies, were included in the study. The morphology of all cases was reviewed with cytogenetic studies. Follow-up details were obtained from the Medical Oncology records. During the study period, 683 Imatinib treated CML patients had bone marrow studies as part of their follow-up investigations. Of these, 60 patients (9%) had some form of persistent cytopenia. The patients ranged from 21 to 75 years of age with a median age of 38 years. The male:female ratio was 1:1. There were 46 patients with ≥grade 2 anemia, 25 patients with ≥grade 2 neutropenia and 37 patients with ≥grade 2 thrombocytopenia. Of these, 18 patients had bicytopenia and 13 cases had pancytopenia. The marrow evaluation revealed morphologic response in 30 patients, persistent marrow disease in five patients, marrow hypoplasia in six patients, extensive stromal changes including fibrosis in five patients, megaloblastic erythropoiesis in 11 patients and disease progression to accelerated or blast crisis in three patients. Various degrees of cytopenias may occur in few patients of CML on imatinib therapy. Regular hematologic follow-up is required so that the drug may be stopped or dose modified as per the individual's needs." @default.
• W2033236638 created "2016-06-24" @default.
• W2033236638 creator A5009713483 @default.
• W2033236638 creator A5049748495 @default.
• W2033236638 creator A5050209246 @default.
• W2033236638 creator A5067372808 @default.
• W2033236638 creator A5073043880 @default.
• W2033236638 creator A5078648514 @default.
• W2033236638 date "2010-06-01" @default.
• W2033236638 modified "2023-09-23" @default.
• W2033236638 title "Evaluation of Cytopenias Occurring in Imatinib Treated Chronic Myeloid Leukemia (CML) Patients" @default.
• W2033236638 cites W1977334021 @default.
• W2033236638 cites W1979577816 @default.
• W2033236638 cites W2013850642 @default.
• W2033236638 cites W2076239625 @default.
• W2033236638 cites W2076538888 @default.
• W2033236638 cites W2088167912 @default.
• W2033236638 cites W2102012621 @default.
• W2033236638 cites W2102764800 @default.
• W2033236638 cites W2119918449 @default.
• W2033236638 cites W2168218213 @default.
• W2033236638 doi "https://doi.org/10.1007/s12288-010-0030-6" @default.
• W2033236638 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3002067" @default.
• W2033236638 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21629637" @default.
• W2033236638 hasPublicationYear "2010" @default.
• W2033236638 type Work @default.
• W2033236638 sameAs 2033236638 @default.
• W2033236638 citedByCount "12" @default.
• W2033236638 countsByYear W20332366382012 @default.
• W2033236638 countsByYear W20332366382017 @default.
• W2033236638 countsByYear W20332366382019 @default.
• W2033236638 countsByYear W20332366382020 @default.
• W2033236638 countsByYear W20332366382021 @default.
• W2033236638 countsByYear W20332366382022 @default.
• W2033236638 crossrefType "journal-article" @default.
• W2033236638 hasAuthorship W2033236638A5009713483 @default.
• W2033236638 hasAuthorship W2033236638A5049748495 @default.
• W2033236638 hasAuthorship W2033236638A5050209246 @default.
• W2033236638 hasAuthorship W2033236638A5067372808 @default.
• W2033236638 hasAuthorship W2033236638A5073043880 @default.
• W2033236638 hasAuthorship W2033236638A5078648514 @default.
• W2033236638 hasBestOaLocation W20332366382 @default.
• W2033236638 hasConcept C104317684 @default.
• W2033236638 hasConcept C126322002 @default.
• W2033236638 hasConcept C174475383 @default.
• W2033236638 hasConcept C185592680 @default.
• W2033236638 hasConcept C194409129 @default.
• W2033236638 hasConcept C2776694085 @default.
• W2033236638 hasConcept C2777063308 @default.
• W2033236638 hasConcept C2777583451 @default.
• W2033236638 hasConcept C2778219007 @default.
• W2033236638 hasConcept C2778248108 @default.
• W2033236638 hasConcept C2778729363 @default.
• W2033236638 hasConcept C2779060813 @default.
• W2033236638 hasConcept C2779382419 @default.
• W2033236638 hasConcept C2780007613 @default.
• W2033236638 hasConcept C2780366003 @default.
• W2033236638 hasConcept C3019892230 @default.
• W2033236638 hasConcept C30481170 @default.
• W2033236638 hasConcept C55493867 @default.
• W2033236638 hasConcept C71924100 @default.
• W2033236638 hasConcept C90924648 @default.
• W2033236638 hasConceptScore W2033236638C104317684 @default.
• W2033236638 hasConceptScore W2033236638C126322002 @default.
• W2033236638 hasConceptScore W2033236638C174475383 @default.
• W2033236638 hasConceptScore W2033236638C185592680 @default.
• W2033236638 hasConceptScore W2033236638C194409129 @default.
• W2033236638 hasConceptScore W2033236638C2776694085 @default.
• W2033236638 hasConceptScore W2033236638C2777063308 @default.
• W2033236638 hasConceptScore W2033236638C2777583451 @default.
• W2033236638 hasConceptScore W2033236638C2778219007 @default.
• W2033236638 hasConceptScore W2033236638C2778248108 @default.
• W2033236638 hasConceptScore W2033236638C2778729363 @default.
• W2033236638 hasConceptScore W2033236638C2779060813 @default.
• W2033236638 hasConceptScore W2033236638C2779382419 @default.
• W2033236638 hasConceptScore W2033236638C2780007613 @default.
• W2033236638 hasConceptScore W2033236638C2780366003 @default.
• W2033236638 hasConceptScore W2033236638C3019892230 @default.
• W2033236638 hasConceptScore W2033236638C30481170 @default.
• W2033236638 hasConceptScore W2033236638C55493867 @default.
• W2033236638 hasConceptScore W2033236638C71924100 @default.
• W2033236638 hasConceptScore W2033236638C90924648 @default.
• W2033236638 hasIssue "2" @default.
• W2033236638 hasLocation W20332366381 @default.
• W2033236638 hasLocation W20332366382 @default.
• W2033236638 hasLocation W20332366383 @default.
• W2033236638 hasLocation W20332366384 @default.
• W2033236638 hasOpenAccess W2033236638 @default.
• W2033236638 hasPrimaryLocation W20332366381 @default.
• W2033236638 hasRelatedWork W1490390872 @default.
• W2033236638 hasRelatedWork W2033236638 @default.
• W2033236638 hasRelatedWork W2065301303 @default.
• W2033236638 hasRelatedWork W2228386951 @default.
• W2033236638 hasRelatedWork W2583718633 @default.
• W2033236638 hasRelatedWork W2600847835 @default.
• W2033236638 hasRelatedWork W3024349535 @default.
• W2033236638 hasRelatedWork W3094458952 @default.
• W2033236638 hasRelatedWork W3209599045 @default.

• next